Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 1Other 1CNS 1

Conditions

Premature Birth 1Polycystic Ovary Syndrome 1Obesity 1Neoplasm Metastasis 1Gliosarcoma 1Glioblastoma 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Utrogestan × Clear all
NCT05091866 2026-05-05

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Emory University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT04175002 2019-11-22

Endometrial Heparin-binding Epidermal Growth Factor Expression

National University of Malaysia

Unknown
40 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT00422526 2007-01-17

Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial

King's College Hospital NHS Trust

Phase 3 Completed
250 enrolled

Neoplasm Metastasis, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡